Results 271 to 280 of about 133,537 (299)

Engineered exosomes for co‐delivery of PGM5‐AS1 and oxaliplatin to reverse drug resistance in colon cancer

Journal of Cellular Physiology, 2021
Oxaliplatin resistance inevitably occurs in almost all cases of metastatic colorectal cancer (CRC), and it is important to study the roles of lncRNAs and their specific regulatory mechanisms in oxaliplatin resistance.
Bingqing Hui, Chen Lu, Jing Wang, Yetao Xu, Yuchen Yang, Hao Ji, Xiaofei Li, Lingyan Xu, Jiawei Wang, Weiwei Tang, Keming Wang, Yanhong Gu   +11 more
semanticscholar   +1 more source

THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer

Molecular Cancer
Cancer-associated fibroblasts (CAFs) exert multiple tumor-promoting functions and are key contributors to drug resistance. The mechanisms by which specific subsets of CAFs facilitate oxaliplatin resistance in colorectal cancer (CRC) have not been fully ...
Xing Zhou, Jiashu Han, Anning Zuo, Yuhao Ba, Shutong Liu, Hui-Xian Xu, Yuyuan Zhang, Siyuan Weng, Zhaokai Zhou, Long Liu, Peng Luo, Quan Cheng, Chuhan Zhang, Yukang Chen, Dan Shan, Benyu Liu, Shuaixi Yang, Xinwei Han, Jinhai Deng, Zaoqu Liu   +19 more
semanticscholar   +1 more source

On‐Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin‐Induced Cancer Immunotherapy

Advances in Materials, 2020
Chemoimmunotherapy‐induced antitumor immune response is highly dependent on tumor autophagy. When tumor cells are treated with chemoimmunotherapy, timely overactivated autophagy can not only lead more tumor cells to death, but also participate in the ...
Xuhui Wang, Man Li, Kebai Ren, C. Xia, Jianping Li, Qianwen Yu, Yue Qiu, Zhengze Lu, Yang Long, Zhirong Zhang, Qin He   +10 more
semanticscholar   +1 more source

Oxaliplatin

Reactions Weekly, 2016
  +7 more sources

Oxaliplatin

Reactions Weekly, 2017
  +6 more sources

Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.

Journal of Clinical Oncology, 2019
PURPOSE We evaluated the role of oxaliplatin as adjuvant chemotherapy in patients with rectal cancer who received preoperative chemoradiotherapy (CRT) with fluoropyrimidine monotherapy and total mesorectal excision (TME).
Y. Hong, S. Kim, Ji Sung Lee, B. Nam, Kyu-pyo Kim, J. E. Kim, Y. Park, Joon-Oh Park, J. Baek, Tae-You Kim, Keun-Wook Lee, J. Ahn, Seok-Byung Lim, C. Yu, J. C. Kim, S. Yun, Jong Hoon Kim, Jin-hong Park, H. Park, K. Jung, Tae Won Kim   +20 more
semanticscholar   +1 more source

Oxaliplatin

Reactions Weekly, 2015
  +5 more sources

Oxaliplatin

Reactions Weekly, 2014
  +5 more sources

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

Journal of Clinical Oncology, 2000
A. Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortés-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Bail, C. Louvet, D. Hendler, F. Braud, C. Wilson, F. Morvan, A. Bonetti   +17 more
semanticscholar   +1 more source

Oxaliplatin

Reactions Weekly, 2011
openaire   +2 more sources